Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.8 (
polynucleotide phosphorylase
)
723
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Escherichia coli cells, made permeable to ribonucleoside-5'-diphosphates by treatment with toluene, efficiently promote the synthesis of homo- and heteropolynucleotides. This synthesis is catalyzed by
polynucleotide phosphorylase
because, among other things, it is inhibited by orthophosphate, and E. coli Q13, a mutant having a Mn-2+-dependent
polynucleotide phosphorylase
, promotes polynucleotide synthesis in the presence of Mn-2+ but not of Mg-2+. Cells of E. coli B and E. coli MRE 600 (A Mutant lacking ribonuclease I) are about equally active in promoting poly(A, U, G, C) synthesis.
Sucrose
density gradient and agarose gel electrophoretic analysis of the product show that it is polydisperse with sedimentation coefficients ranging between 4 S and 27 S. The synthesized polynucleotides can be translated by the toluene-treated cells.
...
PMID:Synthesis of heteropolyribonucleotides by toluene-treated Escherichia coli cells. 109 65